Budesonide_Award_SPE2D219D0075_OFFICIAL_SIGNED.pdf

This document outlines a forthcoming solicitation for a national requirements contract from the Defense Logistics Agency. The solicitation will seek to establish a supply source for Budesonide Inhalation Suspension in 1MG/2ML, 0.25MG/2ML, and 0.5MG/2ML packaging. The contract will have a one year base period and four one year options and utilize firm-fixed pricing. The contract resulting from this solicitation is expected to supply Department of Defense, Bureau of Prisons, Indian Health Service and Department of Veterans Affairs customers through DLA and VA prime vendor programs. Interested parties should monitor the DLA Bid Board System and FEDBIZOPS for posting of the solicitation in August 2018 and contact the identified point of contact for any questions. The document provides relevant details on the procurement including product requirements, contract structure and term, pricing type, federal customers in scope, and response date.